Caplin Point Labs Arm Gets USFDA Approval for Timolol Maleate; Shares Drop 7%
Shares of Caplin Point Laboratories Ltd. dropped 7% after touching a day’s high of Rs 1,611.80 on 8th August, despite the company’s subsidiary receiving final...
Tag : Caplin Point Laboratories Ltd
Caplin Point Shares Gain 2% on USFDA Approval for Eye Treatment Drug
Shares of Caplin Point Laboratories Ltd were trading 2% higher on 16 April after the United States Food and Drug Administration (USFDA) gave its subsidiary...